Back to calendar
Gossamer Bio, Inc. (GOSS) Earnings
GOSS reports earnings on Thursday, November 5, 2026
earnings report
November 5, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.05
Actual EPS: $-0.08
EPS surprise: 35.19%
Company overview
Market Cap$69.6M
PriceUSD 11.39
EPS (TTM)-55.67
52-week high309.60
52-week low9.10
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees162